← Back to Search

Exercise for Lymphoma (HELP Trial)

Phase 3
Waitlist Available
Led By Kerry S Courneya, Ph.D.
Research Sponsored by Lance Armstrong Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

HELP Trial Summary

Objectives: The primary objective of this trial is to determine the effect of aerobic exercise training (AET) on change in quality of life (QoL) in lymphoma survivors receiving and not receiving chemotherapy. Secondary objectives are to determine the effects of AET on changes in psychosocial outcomes, cardiopulmonary fitness, body composition, and treatment completion rates.

HELP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in QoL between baseline and postintervention.
Secondary outcome measures
Changes in cardiopulmonary fitness
body composition
psychosocial outcomes
+1 more

HELP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExerciseExperimental Treatment1 Intervention
Aerobic Exercise Training
Group II: Usual CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic Exercise Training
2020
Completed Phase 4
~5450

Find a Location

Who is running the clinical trial?

Lance Armstrong FoundationLead Sponsor
9 Previous Clinical Trials
929 Total Patients Enrolled
Kerry S Courneya, Ph.D.Principal InvestigatorUniversity of Alberta

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby May 2025